P. Heusler

发表

[3H]-F13640, a novel, selective and high-efficacy serotonin 5-HT1A receptor agonist radioligand

P. Heusler, C. Palmier, S. Tardif, 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

Contribution of muscarinic receptors to in vitro and in vivo effects of Ruscus extract.

P. Heusler, D. Cussac, E. Bouskela, 2017, Microvascular research.

Characterization of V0162, a new long-acting antagonist at human M3 muscarinic acetylcholine receptors.

P. Devillier, P. Heusler, S. Tardif, 2015, Pharmacological research.

Pharmacological evaluation of a series of smoothened antagonists in signaling pathways and after topical application in a depilated mouse model

P. Heusler, S. Tardif, D. Cussac, 2016, Pharmacology research & perspectives.

A repetitive intracortical microstimulation pattern induces long-lasting synaptic depression in brain slices of the rat primary somatosensory cortex

H. Dinse, P. Heusler, G. Boehmer, 2000, Experimental Brain Research.

Potencies and unblocking kinetic properties of antagonists at recombinant human NMDA receptors in a Xenopus oocytes model

P. Heusler, D. Cussac, Amélie Tourette, 2015, Naunyn-Schmiedeberg's Archives of Pharmacology.

μ-Opioid and 5-HT1A receptors heterodimerize and show signalling crosstalk via G protein and MAP-kinase pathways.

P. Heusler, S. Bernois, D. Cussac, 2012, Cellular signalling.

Actions of the prototypical 5-HT1A receptor agonist 8-OH-DPAT at human alpha2-adrenoceptors: (+)8-OH-DPAT, but not (-)8-OH-DPAT is an alpha2B subtype preferential agonist.

P. Heusler, S. Tardif, D. Cussac, 2010, European journal of pharmacology.

Rigid analogues of the α2-adrenergic blocker atipamezole: small changes, big consequences.

P. Heusler, D. Cussac, P. Chopin, 2010, Journal of medicinal chemistry.

Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety

R. Depoortère, P. Heusler, D. Cussac, 2013, Neuropharmacology.

Distinctive in vitro signal transduction profile of NLX‐112, a potent and efficacious serotonin 5‐HT1A receptor agonist

P. Heusler, D. Cussac, A. Newman-Tancredi, 2017, The Journal of pharmacy and pharmacology.

Differential ion current activation by human 5-HT1A receptors in Xenopus oocytes: Evidence for agonist-directed trafficking of receptor signalling

P. Pauwels, P. Heusler, F. Colpaert, 2005, Neuropharmacology.

Activation of G proteins and extracellular signal-regulated kinase 1/2 phosphorylation via human dopamine D4.4 receptors: differential pathway-dependent potencies of receptor agonists

P. Heusler, C. Palmier, S. Tardif, 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist.

P. Sokoloff, P. Heusler, L. Leriche, 2020, European journal of pharmacology.

Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1A receptor agonist

P. Heusler, D. Cussac, A. Newman-Tancredi, 2009, British journal of pharmacology.

Mutant 5-Hydroxytryptamine1A Receptor D116A Is a Receptor Activated Solely by Synthetic Ligands with a Rich Pharmacology

P. Heusler, C. Palmier, S. Tardif, 2009, Journal of Pharmacology and Experimental Therapeutics.

Potencies and unblocking kinetic properties of antagonists at recombinant human NMDA receptors in a Xenopus oocytes model

P. Heusler, D. Cussac, Amélie Tourette, 2015, Naunyn-Schmiedeberg's Archives of Pharmacology.

The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors.

P. Heusler, S. Tardif, D. Cussac, 2011, European journal of pharmacology.

Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells.

P. Heusler, D. Cussac, A. Newman-Tancredi, 2008, The international journal of neuropsychopharmacology.

Differential agonist and inverse agonist profile of antipsychotics at D2L receptors coupled to GIRK potassium channels

P. Heusler, D. Cussac, A. Newman-Tancredi, 2007, Neuropharmacology.

Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells.

P. Heusler, D. Cussac, A. Newman-Tancredi, 2008, European journal of pharmacology.

Platelet-activating factor contributes to the induction of long-term potentiation in the rat somatosensory cortex in vitro

P. Heusler, G. Boehmer, Gerd Boehmer, 2007, Brain Research.

The superoxide anion is involved in the induction of long-term potentiation in the rat somatosensory cortex in vitro

P. Heusler, G. Boehmer, Gerd Boehmer, 2004, Brain Research.

Mutant 5-Hydroxytryptamine1A Receptor D116A Is a Receptor Activated Solely by Synthetic Ligands with a Rich Pharmacology

P. Heusler, C. Palmier, S. Tardif, 2009, Journal of Pharmacology and Experimental Therapeutics.

Agonist stimulation at human μ opioid receptors in a [35S]GTPγS incorporation assay: observation of “bell-shaped” concentration–response relationships under conditions of strong receptor G protein coupling

P. Heusler, S. Tardif, D. Cussac, 2016, Journal of receptor and signal transduction research.